ALFA FinderBSE filing, NSE: HEROMOTOCO. Summary written from the filing by ALFA Finder's alert engine.
Hero MotoCorp Ltd: key numbers
- Share price
- ₹5,352.00
- Market cap
- ₹1,07,127 Cr
- Revenue (annual)
- ₹47,411 Cr
- Net profit (annual)
- ₹5,742 Cr
- P/E (TTM)
- 17.9×Sector 32.5×
- Promoter holding
- 34.72%-0.01% QoQ
- FII holding
- 32.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hero MotoCorp Ltd
All →Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.
Hero MotoCorp Merger & Restructuring
Hero MotoCorp incorporated a wholly-owned CSR subsidiary under Section 8 of the Companies Act on October 29, 2026. The entity 'Hero MotoCorp Foundation' will undertake CSR initiatives.
Hero MotoCorp Business Update
Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.
Hero MotoCorp Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹14,687 Cr (+21% YoY), PAT ₹1,456 Cr (+5%), EBITDA margin 13.4%. Growth driven by volume, mix and pricing; scooter and EV momentum continues.
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Hero MotoCorp Financial Results
Hero MotoCorp reported Q2 FY'27 consolidated revenue of Rs 14,971 Crore and PAT of Rs 1,861 Crore. It also approved up to Rs 300 Crore additional investment in a subsidiary.
Other product launch announcements
All →LTM Product Launch
LTM publishes AI-QEM, its Quantum Error Mitigation tool, in IBM's Quantum Functions Catalog, becoming the first global systems integrator to do so.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.